Gryphon Financial Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gryphon Financial Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$351.14 - $408.51 $16,152 - $18,791	-46 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $11,099 - $13,454	-39 Reduced 45.88%	46 $16,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $8,211 - $10,238	-26 Reduced 23.42%	85 $29,000
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $39,807 - $52,164	111	111 $42,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.